SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-286828
Filing Date
2020-11-05
Accepted
2020-11-05 16:09:38
Documents
95
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d175316d10q.htm   iXBRL 10-Q 4022533
2 EX-10.2 d175316dex102.htm EX-10.2 39154
3 EX-10.3 d175316dex103.htm EX-10.3 25033
4 EX-31.1 d175316dex311.htm EX-31.1 10771
5 EX-31.2 d175316dex312.htm EX-31.2 10756
6 EX-32 d175316dex32.htm EX-32 4315
12 GRAPHIC g175316page12.jpg GRAPHIC 999
  Complete submission text file 0001193125-20-286828.txt   15620912

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA teva-20200930.xsd EX-101.SCH 78924
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20200930_cal.xml EX-101.CAL 46628
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20200930_def.xml EX-101.DEF 533638
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20200930_lab.xml EX-101.LAB 546292
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20200930_pre.xml EX-101.PRE 571508
13 EXTRACTED XBRL INSTANCE DOCUMENT d175316d10q_htm.xml XML 3821714
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 201290503
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences